Fresenius Medical Care Corporation (FMS)vsInnovAge Holding Corp (INNV)
FMS
Fresenius Medical Care Corporation
$22.03
+0.46%
HEALTHCARE · Cap: $12.00B
INNV
InnovAge Holding Corp
$7.08
-1.94%
HEALTHCARE · Cap: $1.22B
Smart Verdict
WallStSmart Research — data-driven comparison
Fresenius Medical Care Corporation generates 1939% more annual revenue ($19.36B vs $949.17M). FMS leads profitability with a 4.9% profit margin vs -1.2%. FMS earns a higher WallStSmart Score of 50/100 (C-).
FMS
Buy50
out of 100
Grade: C-
INNV
Avoid24
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+68.9%
Fair Value
$77.34
Current Price
$22.03
$55.31 discount
Margin of Safety
-25.5%
Fair Value
$6.52
Current Price
$7.08
$0.56 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Attractively priced relative to earnings
Reasonable price relative to book value
Growing faster than its price suggests
15.5% revenue growth
Areas to Watch
Grey zone — moderate risk
ROE of 7.1% — below average capital efficiency
4.9% margin — thin
Revenue declined 5.5%
Distress zone — elevated risk
Smaller company, higher risk/reward
ROE of -9.7% — below average capital efficiency
Earnings declined 87.8%
Comparative Analysis Report
WallStSmart ResearchBull Case : FMS
The strongest argument for FMS centers on P/E Ratio, Price/Book, PEG Ratio. PEG of 0.79 suggests the stock is reasonably priced for its growth.
Bull Case : INNV
The strongest argument for INNV centers on Revenue Growth. Revenue growth of 15.5% demonstrates continued momentum.
Bear Case : FMS
The primary concerns for FMS are Altman Z-Score, Return on Equity, Profit Margin. Thin 4.9% margins leave little buffer for downturns.
Bear Case : INNV
The primary concerns for INNV are Altman Z-Score, Market Cap, Return on Equity.
Key Dynamics to Monitor
FMS profiles as a value stock while INNV is a growth play — different risk/reward profiles.
FMS carries more volatility with a beta of 0.81 — expect wider price swings.
INNV is growing revenue faster at 15.5% — sustainability is the question.
FMS generates stronger free cash flow (37M), providing more financial flexibility.
Bottom Line
FMS scores higher overall (50/100 vs 24/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Fresenius Medical Care Corporation
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America and internationally. The company is headquartered in Bad Homburg, Germany.
Visit Website →InnovAge Holding Corp
HEALTHCARE · MEDICAL CARE FACILITIES · USA
InnovAge Holding Corp. The company is headquartered in Denver, Colorado.
Visit Website →Compare with Other MEDICAL CARE FACILITIES Stocks
Want to dig deeper into these stocks?